Cargando…

A Novel Cardenolide Glycoside Isolated from Xysmalobium undulatum Reduces Levels of the Alzheimer’s Disease-Associated β-Amyloid Peptides Aβ42 In Vitro

Elevated levels of the amylo β-proteins (Aβ), particularly Aβ42, are associated with a high risk of Alzheimer’s disease (AD). The Aβ proteins are produced from cellular processing of the amyloid precursor proteins (APPs). To identify natural products that block the formation of Aβ-proteins from APPs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thakur, Anuradha, Moyo, Phanankosi, van der Westhuizen, Carl Johan, Yang, Hyun Ok, Maharaj, Vinesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400651/ https://www.ncbi.nlm.nih.gov/pubmed/34451840 http://dx.doi.org/10.3390/ph14080743

Ejemplares similares

Anticancer Potential of Sutherlandia frutescens and Xysmalobium undulatum in LS180 Colorectal Cancer Mini-Tumors
por: Gouws, Chrisna, et al.
Publicado: (2021)

A Preliminary Pilot Randomized Crossover Study of Uzara (Xysmalobium undulatum) versus Ibuprofen in the Treatment of Primary Dysmenorrhea
por: Abd-El-Maeboud, Karim H. I., et al.
Publicado: (2014)

Dehydration-responsive features of Atrichum undulatum
por: Hu, Ruoyang, et al.
Publicado: (2016)

Natural Products: A Potential Source of Malaria Transmission Blocking Drugs?
por: Moyo, Phanankosi, et al.
Publicado: (2020)

12β,14-Dihydroxy-3-oxo-5β,20(22)-cardenolide monohydrate
por: He, Chao-Jun, et al.
Publicado: (2010)

Cerebrospinal Fluid Aβ(42/40) Corresponds Better than Aβ(42) to Amyloid PET in Alzheimer’s Disease
por: Lewczuk, Piotr, et al.
Publicado: (2016)

RNAi-mediated gene knockdown of progesterone 5β-reductases in Digitalis lanata reduces 5β-cardenolide content
por: Klein, Jan, et al.
Publicado: (2021)

Use of hyphenated analytical techniques to identify the bioactive constituents of Gunnera perpensa L., a South African medicinal plant, which potently inhibit SARS-CoV-2 spike glycoprotein–host ACE2 binding
por: Invernizzi, Luke, et al.
Publicado: (2022)

Microarray Analysis on Human Neuroblastoma Cells Exposed to Aluminum, β(1–42)-Amyloid or the β(1–42)-Amyloid Aluminum Complex
por: Gatta, Valentina, et al.
Publicado: (2011)

Conjugated Quantum Dots Inhibit the Amyloid β (1–42) Fibrillation Process
por: Thakur, Garima, et al.
Publicado: (2011)

Influence of denaturants on amyloid β42 aggregation kinetics
por: Weiffert, Tanja, et al.
Publicado: (2022)

Influence of Hyperglycemic Conditions on Self-Association of the Alzheimer’s Amyloid β (Aβ(1–42)) Peptide
por: Menon, Sneha, et al.
Publicado: (2017)

Prioritised identification of structural classes of natural products from higher plants in the expedition of antimalarial drug discovery
por: Moyo, Phanankosi, et al.
Publicado: (2023)

Leveraging off higher plant phylogenetic insights for antiplasmodial drug discovery
por: Moyo, Phanankosi, et al.
Publicado: (2023)

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia
por: Bibl, Mirko, et al.
Publicado: (2012)

Derivation of cutoffs for the Elecsys(®) amyloid β (1–42) assay in Alzheimer's disease
por: Shaw, Leslie M., et al.
Publicado: (2018)

Amyloid-β peptide 37, 38 and 40 individually and cooperatively inhibit amyloid-β 42 aggregation
por: Braun, Gabriel A., et al.
Publicado: (2022)

The Cardenolide Glycoside Acovenoside A Interferes with Epidermal Growth Factor Receptor Trafficking in Non-Small Cell Lung Cancer Cells
por: Hafner, Susanne, et al.
Publicado: (2021)

Bioassay-guided isolation and identification of gametocytocidal compounds from Artemisia afra (Asteraceae)
por: Moyo, Phanankosi, et al.
Publicado: (2019)

Human platelets release amyloid peptides β(1-40) and β(1-42) in response to hemostatic, immune, and hypoxic stimuli
por: Wolska, Nina, et al.
Publicado: (2023)

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease
por: Hansson, Oskar, et al.
Publicado: (2019)

Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
por: Fandos, Noelia, et al.
Publicado: (2017)

Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?
por: Klafki, Hans-Wolfgang, et al.
Publicado: (2022)

Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1–40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology
por: Michno, Wojciech, et al.
Publicado: (2019)

Oligomer Formation by Amyloid-β42 in a Membrane-Mimicking Environment in Alzheimer’s Disease
por: Rosenberry, Terrone L., et al.
Publicado: (2022)

Key Residues for the Formation of Aβ42 Amyloid Fibrils
por: Hsu, Frederick, et al.
Publicado: (2018)

Effects and mechanism of amyloid β(1-42) on mitochondria in astrocytes
por: Yao, Yunyi, et al.
Publicado: (2018)

Amyloid β-42 induces neuronal apoptosis by targeting mitochondria
por: Han, Xiao-Jian, et al.
Publicado: (2017)

Misfolded amyloid-β-42 impairs the endosomal–lysosomal pathway
por: Marshall, Karen E., et al.
Publicado: (2020)

Different associations between amyloid-βeta 42, amyloid-βeta 40, and amyloid-βeta 42/40 with soluble phosphorylated-tau and disease burden in Alzheimer’s disease: a cerebrospinal fluid and fluorodeoxyglucose-positron emission tomography study
por: Motta, Caterina, et al.
Publicado: (2023)

Naturally Occurring Cardenolides Affecting Schistosoma mansoni
por: Keiser, Jennifer, et al.
Publicado: (2020)

P‐tau/Aβ42 and Aβ42/40 ratios in CSF are equally predictive of amyloid PET status
por: Campbell, Michelle R., et al.
Publicado: (2021)

Isolation, characterization, and cross‐amplification of 20 microsatellite markers for Conospermum undulatum (Proteaceae)
por: Delnevo, Nicola, et al.
Publicado: (2019)

High Soluble Amyloid-β(42) Predicts Normal Cognition in Amyloid-Positive Individuals with Alzheimer’s Disease-Causing Mutations
por: Sturchio, Andrea, et al.
Publicado: (2022)

Cerebrospinal fluid ratios with Aβ(42) predict preclinical brain β-amyloid accumulation
por: Racine, Annie M., et al.
Publicado: (2015)

Amyloid β-peptides 1–40 and 1–42 form oligomers with mixed β-sheets
por: Baldassarre, Maurizio, et al.
Publicado: (2017)

Formation of the 42-mer Amyloid β Radical and the Therapeutic Role of Superoxide Dismutase in Alzheimer's Disease
por: Murakami, Kazuma, et al.
Publicado: (2011)

Aβ(1–42) Fibril Structure Illuminates Self-recognition and Replication of Amyloid in Alzheimer’s
por: Xiao, Yiling, et al.
Publicado: (2015)

Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease
por: Janelidze, Shorena, et al.
Publicado: (2021)

Aβ42-oligomer Interacting Peptide (AIP) neutralizes toxic amyloid-β42 species and protects synaptic structure and function
por: Barucker, Christian, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_umf58n9nkmmikof2go631mb5sc